Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Knowledge Base SDTM Disease Registry Entry Form and other Auhortities Clinical Trial Sponsor Case Report Form Outbreak Report Adverse Event Data EHR Safety Org. From Landen Bain’s presentation at the Clinical Observations Interoperability Telcon, 28 August 2007, with some minor additions relevant for Drug Development Primary Use in Health Care per patient Primary use in Drug Development (i.e. Secondary Use of Health Care data in clinical research) Secondary Use in Health Care as Knowledge Base Subject SDTM Auhortities Patient Secondary Use Epi / Population / Real life analysis Secondary Use in Drug Development as Knowledge Base Organizing clinical trials information that is to be submitted to the FDA. TRIAL DESIGN MODEL Trial Summary Parameter domain e.g AGESPAN and SEXPOP Trial Inclusion/Exclusion Criteria domain SDTM Auhortities Inclusion/Exclusion Criterion Not Met (findings domain) Refeering back to IETESTCD CLINICAL OBSERVATIONS per SUBJECT such as Demographics (special purpose domain) with fixed variables such as SEX, BRTHDTC, AGE / AGEU Medical History (events domain) Using MedDRA Vital Signs and Subject Characteristics (findings domain) Using Controlled Terminologies of Test Codes Concomitant Medications and Substance Use (interventions domain) Backup slides Background to SDTM CDISC SDTM and related initativies All terms and concepts are incorporated from NCI Thesaurus thorugh NCI EVS Relationship HL7/CDISC SDTM variables specified as packages of Controlled Terminologies Published as an Excel matrixes on CDISC website In OWL format CDISC Clinical Data Interchange Standards Consortium RCRIM Regulated Clinical Research and Information Management, technical committee HL7 “Health Level Seven” NCI Thesaurus UMLS BRIDG Biomedical Research Integrated Domain Group Model CDISC SDTM’s Domains Interventions Events Findings Other Exposure AE Labs Incl Excl* Demog ConMeds Disposition Vitals Subj Char* RELATES* SUPPQUAL* Subst Use* MedHist PhysExam ECG QS*, MB* CP*, DV* From CDISC SDTM Overview & Impact to AZ, 2004, by Dan Godoy, presented at the first CDISC/SDM meeting 20 October 2004 Comments* Study Design* Study Sum* Basic Concepts in CDISC SDTM Observations and Variables • The SDTM provides a general framework for describing the organization of information collected during human and animal studies. • The model is built around the concept of observations, which consist of discrete pieces of information collected during a study. Observations normally correspond to rows in a dataset. • Each observation can be described by a series of named variables. Each variable, which normally corresponds to a column in a dataset, can be classified according to its Role. • Observations are reported in a series of domains, usually corresponding to data that were collected together. A domain is defined as a collection of observations with a topic-specific commonality about a subject. From the Study Data Tabulation Model document Basic Concepts in CDISC SDTM Variable Roles • • • • Topic variables Identifier variables Timing variables Rule variables • Qualifier variables – – – – – Grouping Qualifiers Result Qualifiers Synonym Qualifiers Record Qualifiers Variable Qualifiers An example of a SDTM dataset (Vital Sign domain) Observation Record Topic Identifier Timing Grouping Synonym Qual Qual Res Res Qual Generic dataset structure for all domains Based on the descriptions in the Study Data Tabulation Model document Var Var Qual Record Qual